Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
Shares of bioplastics and radio-frequency technology Biome Technologies (LON: BIOM) have plunged Wednesday after it warned revenues for 2021 will be significantly below current market expectations due to supply chain problems.
Biome shares are down over 16% at 214p at the time of writing.
The company's revenues in Q3 were £1.1 million compared to 2020s £1.8m. Biome's cash position on 30 September was £1 million.
Looking ahead, the AIM-quoted firm said in the short term it expects more challenges, and it now believes revenues from certain customers of the Bioplastics division will be delayed into the first half of 2022.
In addition, the EBITDA loss for the year will be only slightly greater than current market expectations, Biome told investors.
“Whilst the issues highlighted above have stretched the Group's working capital resources in 2021, the Directors believe that actions underway will improve the efficiency of Biome's working capital cycle over time in a continuing process to release cash,” said the company.
Biome Technologies shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are Biome Technologies shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .